Concepedia

Iván Márquez‐Rodas

IM

80

Publications

27.8K

Citations

39

H-Index

2004

Active since

Affiliations

Hospital General Universitario Gregorio Marañón(Current)

Centro de Investigación Biomédica en Red de Cáncer

Bristol-Myers Squibb (United States)

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Princess Margaret Cancer Centre

Iván Márquez‐Rodas is an author at Hospital General Universitario Gregorio Marañón specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2004–2024

80

Publications

80

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8K citations · Full text

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.3K citations · Full text

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2019 · 3.6K citations · Full text

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Jeffrey S. Weber, Mario Mandalà, Michele Del Vecchio et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

F. Stephen Hodi, Vanna Chiarion‐Sileni, René González et al. · The Lancet Oncology · 2018 · 1.4K citations

, , +7

Rows per page

1–5 of 80